Protara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARA and other ETFs, options, and stocks.About TARA
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders.
CEOJesse Shefferman
CEOJesse Shefferman
Employees33
Employees33
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2006
Founded2006
Employees33
Employees33
TARA Key Statistics
Market cap274.68M
Market cap274.68M
Price-Earnings ratio-3.69
Price-Earnings ratio-3.69
Dividend yield—
Dividend yield—
Average volume530.45K
Average volume530.45K
High today$5.36
High today$5.36
Low today$5.18
Low today$5.18
Open price$5.24
Open price$5.24
Volume586.14K
Volume586.14K
52 Week high$7.82
52 Week high$7.82
52 Week low$2.77
52 Week low$2.77
Stock Snapshot
As of today, Protara Therapeutics(TARA) shares are valued at $5.27. The company's market cap stands at 274.68M, with a P/E ratio of -3.69.
As of 2026-01-01, Protara Therapeutics(TARA) stock has fluctuated between $5.18 and $5.36. The current price stands at $5.27, placing the stock +1.7% above today's low and -1.7% off the high.
The Protara Therapeutics(TARA)'s current trading volume is 586.14K, compared to an average daily volume of 530.45K.
In the last year, Protara Therapeutics(TARA) shares hit a 52-week high of $7.82 and a 52-week low of $2.77.
In the last year, Protara Therapeutics(TARA) shares hit a 52-week high of $7.82 and a 52-week low of $2.77.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TARA. This list is generated using Robinhood data, and it’s not a recommendation.